First Page | Document Content | |
---|---|---|
Date: 2016-07-01 14:54:26 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotheAdd to Reading ListSource URL: www.ovarian.orgDownload Document from Source WebsiteFile Size: 356,72 KBShare Document on Facebook |